Insider Transactions in Q2 2021 at Zosano Pharma Corp (ZSANQ)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
Joseph P Hagan Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+40.0%
|
-
|
|
Jun 10
2021
|
Kleanthis G Xanthopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+38.86%
|
-
|
|
Jun 10
2021
|
Kenneth Greathouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+21.9%
|
-
|
|
Jun 10
2021
|
Steve Elms Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+40.0%
|
-
|
|
Jun 10
2021
|
Linda Grais Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+40.0%
|
-
|
|
Jun 04
2021
|
Christine Matthews Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,709
-1.71%
|
$0
$0.8 P/Share
|
|
Jun 04
2021
|
Donald J Kellerman VP, Clinical Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
1,709
-3.28%
|
$0
$0.8 P/Share
|
|
Jun 04
2021
|
Hayley Lewis Officer |
SELL
Open market or private sale
|
Direct |
1,709
-3.32%
|
$0
$0.8 P/Share
|
|
Jun 04
2021
|
Steven Lo Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,158
-3.47%
|
$0
$0.8 P/Share
|
|
May 17
2021
|
Kenneth Greathouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+35.29%
|
$0
$0.73 P/Share
|